EUVIMEDEUVIMED entdecken
BeobachtungsstudieKohortenstudie

Early Induction Outcomes in Acute Myeloid Leukemia: Impact of Clinical Status, Infectious Complications, Cardiometabolic Comorbidities, and Diagnostic Features in a Cohort Study.

Ahmed Akef, Maysa Aly, Mohamed Hanafy Morsy, Ola Abd Elfattah Ali Amro, Fatma M Elsayed, Heba Yahia Elkholy, Murad Barakat, Loai Emam, Amira N Ahmed, Lama M El-Attar, Peter Makram Thabet Matta, Salwa M Abdelhamid und 3 weitere

La Clinica Terapeutica · 01.09.2026 · 177 (5) · 1117-1130

DOI: 10.7417/ct.2026.2113 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift La Clinica Terapeutica, erschienen am 01.09.2026. Verfasst von Ahmed Akef und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Induction Chemotherapy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Induction chemotherapy outcomes in acute myeloid leukemia (AML) remain suboptimal in many low- and middle-income countries due to delayed diagnosis, limited supportive care resources, and treatment-related complications. Data regarding predictors of induction outcomes in resource-limited settings remain scarce. This study aimed to evaluate day-28 induction outcomes and identify clinical, laboratory, infectious, comorbidity-related, and diagnostic factors associated with unfavorable induction outcomes in adult AML patients.

Methods

This observational cohort study included 90 adult patients with newly diagnosed non-acute promyelocytic leukemia (non-APL) AML who received induction chemotherapy between January 2020 and December 2024 at Al-Azhar University Hospitals, Cairo, Egypt. Day-28 induction outcomes were categorized as complete remission (CR), refractory disease (R), or induction-related death (IID). Unfavorable induction outcome was defined as refractory disease or IID. Baseline demographic, clinical, laboratory, infectious, comorbidity, immunophenotypic, and cytogenetic variables were analyzed using univariate and multivariate logistic regression models.

Results

Among the 90 patients, 53 (58.9%) achieved CR, 20 (22.2%) had refractory disease, and 17 (18.9%) experienced IID. Poor ECOG performance status (≥2) was significantly associated with unfavorable induction outcomes in both univariate (OR = 4.58, 95% CI: 1.74 - 12.08, P = 0.002) and multivariate analyses (OR = 3.96, 95% CI: 1.39 - 11.27, P = 0.010). Severe thrombocytopenia (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteInduction ChemotherapyHumansMaleFemaleAdultMiddle AgedCohort StudiesComorbidityTreatment OutcomeRemission InductionEgyptAgedTime Factors

Stichwörter der Autor:innen

Acute myeloid leukemia; Induction chemotherapy; Complete remission; Refractory…

Autor:innen und Institutionen

  • Department of Clinical Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
  • Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Department of Clinical Pathology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
  • Geriatric Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
  • Department of Internal Medicine, Hematology Unit, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
  • Internal Medicine Department, Faculty of Medicine, Menoufia University, Egypt.

Zitieren

APA

Akef, A., Aly, M., Morsy, M. H., Amro, O. A. E. A., Elsayed, F. M., Elkholy, H. Y., Barakat, M., Emam, L., Ahmed, A. N., El-Attar, L. M., Matta, P. M. T., Abdelhamid, S. M., Ahmed, W. M. K., Ibrahim, E., & Shalaby, N. (2026). Early Induction Outcomes in Acute Myeloid Leukemia: Impact of Clinical Status, Infectious Complications, Cardiometabolic Comorbidities, and Diagnostic Features in a Cohort Study. La Clinica Terapeutica, 177(5), 1117-1130. https://doi.org/10.7417/ct.2026.2113

Vancouver

Akef A, Aly M, Morsy MH, Amro OAEA, Elsayed FM, Elkholy HY, et al. Early Induction Outcomes in Acute Myeloid Leukemia: Impact of Clinical Status, Infectious Complications, Cardiometabolic Comorbidities, and Diagnostic Features in a Cohort Study. La Clinica Terapeutica. 2026;177(5):1117-1130. doi:10.7417/ct.2026.2113

BibTeX
@article{Akef2026,
  author = {Akef, Ahmed and Aly, Maysa and Morsy, Mohamed Hanafy and Amro, Ola Abd Elfattah Ali and Elsayed, Fatma M and Elkholy, Heba Yahia and Barakat, Murad and Emam, Loai and Ahmed, Amira N and El-Attar, Lama M and Matta, Peter Makram Thabet and Abdelhamid, Salwa M and Ahmed, Walid Mohamed Kamel and Ibrahim, Eiman and Shalaby, Neveen},
  title = {Early Induction Outcomes in Acute Myeloid Leukemia: Impact of Clinical Status, Infectious Complications, Cardiometabolic Comorbidities, and Diagnostic Features in a Cohort Study},
  journal = {La Clinica Terapeutica},
  year = {2026},
  volume = {177},
  number = {5},
  pages = {1117--1130},
  doi = {10.7417/ct.2026.2113}
}
Kostenlos starten →